Pfeiffenberger Brent Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$28,554.03

Insider Activity of Pfeiffenberger Brent

According to the SEC Form 4 filings, Pfeiffenberger Brent, being in a position of

  1. President and CEO at Century Therapeutics, Inc.,
    оver the last 12 months, has bought 87000 shares for $47,681, and sold 32456 shares for $14,735,
    over all time since 2025-02-18, has bought 87000 shares for $47,681, and sold 99918 shares for $59,964.

Biography of Pfeiffenberger Brent

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $47,681267
Sells
 $14,735133

Comparison of Insiders on Amount of Buys and Sells

2025-12-12PurchaseCentury Therapeutics, Inc.
IPSC
President and CEO
52,000
0.0629%
$0.58$30,352+280.13%
2025-11-19PurchaseCentury Therapeutics, Inc.
IPSC
President and CEO
35,000
0.0387%
$0.50$17,329+304.33%
2025-11-17SaleCentury Therapeutics, Inc.
IPSC
President and CEO
32,456
0.0355%
$0.45$14,735+330.98%
2025-09-08SaleCentury Therapeutics, Inc.
IPSC
President and CEO
488
0.0006%
$0.50$244+303.68%
2025-06-09SaleCentury Therapeutics, Inc.
IPSC
President and CEO
475
0.0005%
$0.62$295-0.69%
2025-05-16SaleCentury Therapeutics, Inc.
IPSC
President and CEO
29,552
0.0334%
$0.55$16,135+5.69%
2025-03-10SaleCentury Therapeutics, Inc.
IPSC
President and CEO
2,235
0.0027%
$0.61$1,375-7.57%
2025-02-18SaleCentury Therapeutics, Inc.
IPSC
President and CEO
34,712
0.0413%
$0.78$27,180-26.78%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.